George A. Pashkov

George A. Pashkov

Auto-generated profile, based on publicly available information

George A. Pashkov

I. Mechnikov Research Institute of Vaccines and Sera

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2025 in Problems of Virology
Verified
Journal Article
Open access
PDF file
DSDmitry A. Shikvin
Dmitry A. Shikvin
GPGeorge A. Pashkov
George A. Pashkov
FNFiraya G. Nagieva
Firaya G. Nagieva
EBEkaterina A. Bogdanova
Ekaterina A. Bogdanova
ABAnatoly S. Bykov
Anatoly S. Bykov
VZVitaly V. Zverev
Vitaly V. Zverev
Introduction. Influenza is an acute respiratory viral infectious disease caused by the influenza viruses. Current preventive and therapeutic approaches are of great anti-epidemic importance, but there are a number of problems, such as the rapid emergence of resistant strains, the lack of cross-immunity and the effectiveness of vaccines. One of the approaches to the development of anti-influenza agents is the use of RNA interference and small interfering RNAs complementary to the mRNA target of viral and cellular genes. Aim ‒ to evaluate the prophylactic anti-influenza effect of siRNAs directed to the cellular genes NXF1, PRPS1 and NAA10 in an in vitro model. Materials and methods. Antigenic variants of influenza A virus: A/California/7/09 (H1N1), A/WSN/33 (H1N1) and A/Brisbane/59/07 (H1N1); cell cultures A549 and MDCK. The study was performed using molecular genetic (transfection, NC isolation, RT-PCR-RV) and virological (cell culture infection, titration by visual CPE, viral titer assessment using the Ramakrishnan method) methods. Results. It was shown that siRNAs targeting the cellular genes NXF1, PRPS1 and NAA10, when used prophylactically in cell culture at a concentration of 0.25 μg per well, during infection with influenza virus strains A/California/7/09 (H1N1), A/WSN/33 (H1N1) and A/Brisbane/59/07 (H1N1) at a multiplicity of infection of 0.01, reduced viral replication to a level of 220 TCID50 per 1 ml of cell medium, whereas in control untreated cells the viral yield was ~106 TCID50 per 1 ml of medium. Conclusions. Reproduction of influenza A viruses directly depends on the protein products of the NXF1, PRPS1, and NAA10 genes. Reduced expression of these genes disrupts the life cycle and activity of influenza viruses. Such an approach can potentially be studied and used for closely and distantly related representatives of other virus families.

18 May 2023 in Problems of Virology
Verified
Journal Article
Open access
PDF file
VMViktoriia Y. Momot
Viktoriia Y. Momot
APAnastasia V. Pak
Anastasia V. Pak
RSRoman V. Samoilikov
Roman V. Samoilikov
GPGeorge A. Pashkov
George A. Pashkov
GUGalina N. Usatova
Galina N. Usatova
VZVitaliy V. Zverev
Vitaliy V. Zverev
Introduction. Influenza is one of the most pressing global health problems. Despite the wide range of available anti-influenza drugs, the viral drug resistance is an increasing concern and requires the search for new approaches to overcome it. A promising solution is the development of drugs with action that is based on the inhibition of the activity of cellular genes through RNA interference. Aim. Evaluation in vivo of the preventive potential of miRNAs directed to the cellular genes FLT4, Nup98 and Nup205 against influenza infection. Materials and methods. The A/California/7/09 strain of influenza virus (H1N1) and BALB/c mice were used in the study. The administration of siRNA and experimental infection of animals were performed intranasally. The results of the experiment were analyzed using molecular genetic and virological methods. Results. The use of siRNA complexes Nup98.1 and Nup205.1 led to a significant decrease in viral reproduction and concentration of viral RNA on the 3rd day after infection. When two siRNA complexes (Nup98.1 and Nup205.1) were administered simultaneously, a significant decrease in viral titer and concentration of viral RNA was also noted compared with the control groups. Conclusions. The use of siRNAs in vivo can lead to an antiviral effect when the activity of single or several cellular genes is suppressed. The results indicate that the use of siRNAs targeting the cellular genes whose expression products are involved in viral reproduction is one of the promising methods for the prevention and treatment of not only influenza, but also other respiratory infections.

26 February 2026 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
EPEvgenij Pashkov
Evgenij Pashkov
GPGeorge A. Pashkov
George A. Pashkov
FNFiraya G. Nagieva
Firaya G. Nagieva
AMAlena A. Murzina
Alena A. Murzina
ISIrina B. Semenova
Irina B. Semenova
VZVitaliy V. Zverev
Vitaliy V. Zverev
Introduction. Among infectious lesions of the upper respiratory tract and lungs, the leading positions are occupied by infections associated with the influenza A virus. The currently used means of prevention and therapy cannot completely prevent the spread of influenza among the population; therefore, it is necessary to search for fundamentally new approaches, the use of which will overcome the problem of high morbidity and drug resistance. Currently, the phenomenon of RNA interference (RNAi) is increasingly establishing itself as a powerful tool in the suppression of viral reproduction. Previously, it was believed that viral genes serve as a classic target for RNAi, however, given the high variability of the influenza A virus and its drug resistance, it is more logical to shift the focus to the use of host cellular factors necessary for viral reproduction as targets. This approach will have a number of advantages, such as multidirectionality against a wide range of taxonomic groups of viruses whose reproduction mechanism may be similar, rapid design of similar compounds against "emergent" viruses, as well as synergy with other antiviral agents. The aim is to evaluate the anti-influenza effect of siRNAs targeting the NXF1, PRPS1 and NAA10 cellular genes in an in vivo model. Materials and methods. The influenza A/California/7/09 (H1N1)pdm09 virus strain adapted to Balb/c laboratory mice, as well as the L929 and MDCK cell cultures, were used. The study was carried out using biological (infection of laboratory animals), molecular genetic (transfection, nucleic acid isolation, real-time polymerase chain reaction with reverse transcription) and virological methods (titration by visual cytopathic effect, assessment of viral titer using the Ramakrishnan method). Results. It was shown that siRNAs targeting the NXF1, PRPS1 and NAA10 cellular genes, when used prophylactically in an in vivo model at a concentration of 1.5 nmol/μL, during infection with influenza virus strains A/California/7/09 (H1N1), at mouse semi-lethal doses (LD50), reduce viral replication to a level of 3.1 log10 TCID50/mL of cell medium, the amount of vRNA — to 3.2 log10 compared to the groups of non-specific and viral controls. Conclusions. A decrease in the expression of the NXF1, PRPS1 and NAA10 genes leads to a disruption of the life cycle and activity of influenza viruses. This approach can potentially be studied and used for closely and distantly related representatives of other virus families.